Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Consolidated Net Profit

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹381 Cr₹314 Cr₹266 Cr₹185 Cr₹236 Cr

What is the latest Consolidated Net Profit of MARKSANS PHARMA ?

The latest Consolidated Net Profit ratio of MARKSANS PHARMA is ₹381 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹381 Cr
Mar2025₹314 Cr
Mar2024₹266 Cr
Mar2023₹185 Cr
Mar2022₹236 Cr

How is Consolidated Net Profit of MARKSANS PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹381 Cr
21.32
Mar2025 ₹314 Cr
17.80
Mar2024 ₹266 Cr
44.29
Mar2023 ₹185 Cr
-21.77
Mar2022 ₹236 Cr -

Compare Consolidated Net Profit of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,342.2 Cr -4.4% -12.9% 64.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,831.0 Cr -0.4% -6.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,074.0 Cr 0.9% -3.3% 39.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,355.0 Cr 0.1% -7.2% 28.2% Stock Analytics
CIPLA ₹107,439.0 Cr -0.3% -4% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,417.0 Cr 1.5% 3.1% 0.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.4%

-12.9%

64.6%

SENSEX

0.6%

-1.4%

-10.7%


You may also like the below Video Courses